MA38636A1 - 3,4-Dihydroisoquinolin-2 (1h) -yl compounds - Google Patents

3,4-Dihydroisoquinolin-2 (1h) -yl compounds

Info

Publication number
MA38636A1
MA38636A1 MA38636A MA38636A MA38636A1 MA 38636 A1 MA38636 A1 MA 38636A1 MA 38636 A MA38636 A MA 38636A MA 38636 A MA38636 A MA 38636A MA 38636 A1 MA38636 A1 MA 38636A1
Authority
MA
Morocco
Prior art keywords
compounds
dihydroisoquinolin
formula
schizophrenia
parkinson
Prior art date
Application number
MA38636A
Other languages
French (fr)
Inventor
Christopher David Beadle
David Andrew Coates
Junliang Hao
Jr Joseph Herman Krushinski
Matthew Robert Reinhard
John Mehnert Schaus
Craig Daniel Wolfangel
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority claimed from PCT/US2014/039494 external-priority patent/WO2014193781A1/en
Publication of MA38636A1 publication Critical patent/MA38636A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne certains composés de 3,4-dihydroisoquinoléin-2(1h)-yle, notamment des composés de formule (i), et des compositions pharmaceutiques correspondantes. L'invention concerne en outre des procédés d'utilisation d'un composé de formule (i) pour traiter la déficience cognitive associée à la maladie de parkinson ou à la schizophrénie.The invention relates to certain 3,4-dihydroisoquinolin-2 (1h) -yl compounds, especially compounds of formula (i), and corresponding pharmaceutical compositions. The invention further provides methods of using a compound of formula (i) to treat cognitive impairment associated with Parkinson's disease or schizophrenia.

MA38636A 2013-05-30 2014-05-27 3,4-Dihydroisoquinolin-2 (1h) -yl compounds MA38636A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361828740P 2013-05-30 2013-05-30
PCT/US2014/039494 WO2014193781A1 (en) 2013-05-30 2014-05-27 3,4-dihydroisoquinolin-2(1h)-yl compounds

Publications (1)

Publication Number Publication Date
MA38636A1 true MA38636A1 (en) 2017-09-29

Family

ID=56120452

Family Applications (1)

Application Number Title Priority Date Filing Date
MA38636A MA38636A1 (en) 2013-05-30 2014-05-27 3,4-Dihydroisoquinolin-2 (1h) -yl compounds

Country Status (2)

Country Link
AR (1) AR096310A1 (en)
MA (1) MA38636A1 (en)

Also Published As

Publication number Publication date
AR096310A1 (en) 2015-12-23

Similar Documents

Publication Publication Date Title
PH12015502658A1 (en) 3,4-dihydroisoquinolin-2 (1h)-yl compounds
MA43518A (en) 3-AZABICYCLO [3.1.0] SUBSTITUTED HEXANES SERVING AS KETOHEXOKINASE INHIBITORS
MA35905B1 (en) Amidine-substituted beta-lactam compounds, their preparation and their use as antibacterial agents
MA39211B1 (en) Tricyclic compounds as anti-cancer agents
GEP20166554B (en) Nitrogenated heterocyclic compound
MA39152B1 (en) 1,2-substituted cyclopentanes used as orexin receptor antagonists
MA43409B1 (en) Polycyclic compounds for use as bruton tyrosine kinase inhibitors
MA37886A1 (en) New bicyclic pyridinones
MA34968B1 (en) ASYMMETRIC UREA AND MEDICAL USES THEREOF
MA35816B1 (en) Aniline derivatives, their preparation and their therapeutic application
MA38884A1 (en) Triazolopyridine compound, compositions and methods of use thereof
MA34384B1 (en) HETEROCYCLIC COMPOUNDS, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
MA39171A1 (en) Hydroxy formamide derivatives and their use
MA40366A (en) TETRAHYDROQUINOLINE DERIVATIVES AS BROMODOMA INHIBITORS
NZ746906A (en) Oxaborole esters and uses thereof
MA37650A1 (en) Amorphous form of an akt-inhibiting pyrimidinyl-cyclopentane compound, compositions and methods thereof
EA201691831A1 (en) HETEROAROMATIC COMPOUNDS AND THEIR APPLICATION AS DOPAMINE D1 LIGANDS
MA39315A1 (en) Pyridazine derivatives for use in the prevention or treatment of ataxic disorder
EP4353310A3 (en) Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists
MA43250B1 (en) Oxadiazaspiro compounds for the treatment of drug abuse and dependence
EA201691788A1 (en) HETEROAROMATIC COMPOUNDS AND THEIR APPLICATION AS DOPAMINE D1 LIGANDS
MA39253B1 (en) Substituted bicyclic heteroaryl compounds used as rxr agonists
MA37700B1 (en) N- [4- (quinolin-4-yloxy) cyclohexyl (methyl)] (hetero) arylcarboxamides for use as androgen receptor antagonists, their production and their use as medicaments
MA37999B1 (en) Macrolide derivatives, their preparation and their therapeutic use
MA38636A1 (en) 3,4-Dihydroisoquinolin-2 (1h) -yl compounds